PMID: 6151347Jan 1, 1984Paper

Experience with triazolam as a preoperative sedative for outpatient surgery under local anesthesia

Aesthetic Plastic Surgery
R Riefkohl, R Kosanin

Abstract

Triazolam, a new benzodiazepine hypnotic agent with an ultra-short duration of action, was given preoperatively to 251 outpatients who underwent plastic surgical procedures under local anesthesia. Satisfactory sedation was obtained in 96% of the patients, all of whom received intravenous diazepam primarily for its amnesic action. There were no untoward results attributed to triazolam and no residual effects postoperatively. Triazolam may be preferable over other benzodiazepine sedative-hypnotic agents used for outpatient surgery because of its rapid onset and short half-life.

References

Nov 7, 1974·The New England Journal of Medicine·D J Greenblatt, R I Shader
Dec 5, 1974·The New England Journal of Medicine·D J Greenblatt, R I Shader
Jan 1, 1980·Psychopharmacology·C OguraW M Wardell
Sep 27, 1980·British Medical Journal·M R KeighleyR J Gammon
Jan 1, 1982·Sleep·D J GreenblattR I Shader

Citations

Sep 1, 1993·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·V K KontinenJ Sarvela
Oct 1, 1995·Canadian Journal of Anaesthesia = Journal Canadien D'anesthésie·H J PenttiläA M Partanen
Aug 1, 1997·Oral Surgery, Oral Medicine, Oral Pathology, Oral Radiology, and Endodontics·C W BertholdS E Corey
Nov 1, 1993·The Journal of the American Dental Association·C W BertholdR A Dionne
Apr 25, 2012·Annals of the New York Academy of Sciences·Katie Overy

Related Concepts

Surgery, Day
Neural Therapy of Huneke
Vigilance, Cortical
Dose-Response Relationship, Drug
Hemodynamics
Premedication
Esthetic Surgery
Anti-Anxiety Effect
Trilam

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Lipidomics & Rhinovirus Infection

Lipidomics can be used to examine the lipid species involved with pathogenic conditions, such as viral associated inflammation. Discovered the latest research on Lipidomics & Rhinovirus Infection.

Alzheimer's Disease: MS4A

Variants within the membrane-spanning 4-domains subfamily A (MS4A) gene cluster have recently been implicated in Alzheimer's disease in genome-wide association studies. Here is the latest research on Alzheimer's disease and MS4A.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Torsion Dystonia

Torsion dystonia is a movement disorder characterized by loss of control of voluntary movements appearing as sustained muscle contractions and/or abnormal postures. Here is the latest research.

Generating Insulin-Secreting Cells

Reprogramming cells or using induced pluripotent stem cells to generate insulin-secreting cells has significant therapeutic implications for diabetics. Here is the latest research on generation of insulin-secreting cells.

Central Pontine Myelinolysis

Central Pontine Myelinolysis is a neurologic disorder caused most frequently by rapid correction of hyponatremia and is characterized by demyelination that affects the central portion of the base of the pons. Here is the latest research on this disease.

Epigenome Editing

Epigenome editing is the directed modification of epigenetic marks on chromatin at specified loci. This tool has many applications in research as well as in the clinic. Find the latest research on epigenome editing here.